Online citations, reference lists, and bibliographies.
← Back to Search

Evaluation Of Pilocarpine-loaded Albumin Particles As Drug Delivery Systems For Controlled Delivery In The Eye. I: In Vitro And In Vivo Characterisation

A. Zimmer, Horst G. Zerbe, J. Kreuter
Published 1994 · Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
Abstract The loading of pilocarpine on albumin microspheres and nanospheres was optimised. Optimal loading conditions were obtained with 2% pilocarpine and a particle concentration of 20 to 40 mg particles ml . Due to their high surface area nanoparticles exhibited the highest loading. The in vitro release of the albumin panicle carrier systems differing in size was measured by simulating the rapid drug dilution as occurring in the eye. All particle fractions released pilocarpine completely within a few minutes. The systems were further tested in vivo by determination of their miotic and IOP-lowering properties. Independent of the size, pilocarpine-loaded albumin particles increased the bioavailability of pilocarpine by about 50–90% (miosis), and 50–70% (IOP) respectively, compared to a pilocarpine reference solution. The best results were obtained with albumin nanoparticles with 2% pilocarpine (total concentration) at a particle concentration of 40 mg ml .
This paper references
10.1111/j.1755-3768.1979.tb00505.x
PHAGOCYTOSIS OF LATEX MICROSPHERES BY THE EPITHELIAL CELLS OF THE GUINEA PIG CONJUNCTIVA
S. Latkovic (1979)
10.1016/0378-5173(85)90199-1
Pilocarpine release from matrices of alkyl half-esters of poly(vinyl methyl ether/maleic anhydride)
A. Urtti (1985)
10.1016/0378-5173(90)90248-3
Antiglaucomatous activity of betaxolol chlorhydrate sorbed onto different isobutylcyanoacrylate nanoparticle preparations
L. Marchal-Heussler (1990)
CommunicationsAlbumin Microspheres as Vehicles for Achieving Specificity in Drug Delivery
Paul A. Kramer (1974)
A bioavailability comparison in rabbits of two steroids formulated as high-viscosity gels and reference aqueous preparations.
R. Schoenwald (1979)
10.1002/JPS.2600690407
Effect of particle size on ophthalmic bioavailability of dexamethasone suspensions in rabbits.
R. Schoenwald (1980)
Liposomes in topical drug delivery.
H. E. Schaeffer (1982)
Determination of tear volume and tear flow.
S. Mishima (1966)
10.1002/JPS.2600680124
Magnetic microspheres: synthesis of a novel parenteral drug carrier.
K. Widder (1979)
10.1016/0378-5173(85)90007-9
Ocular disposition of poly-hexyl-2-cyano[3-14C]acrylate nanoparticles in the albino rabbit
R. Wood (1985)
10.1016/0378-5173(85)90230-3
Ocular delivery of progesterone using a bioadhesive polymer
Ho-Wah Hui (1985)
10.1016/0378-5173(86)90053-0
Enhancement of the myotic response of rabbits with pilocarpine-loaded polybutylcyanoacrylate nanoparticles
T. Harmia (1986)
10.1016/0378-5173(86)90160-2
Semisolid ophthalmic vehicles. III. An evaluation of four organic hydrogels containing pilocarpine
M. Saettone (1986)
10.1016/S0076-6879(85)12003-3
Albumin microspheres: heat and chemical stabilization.
A. F. Yapel (1985)
10.1002/JPS.2600630810
Ocular evaluation of methylcellulose vehicle in albino rabbits.
S. Chrai (1974)
10.1083/JCB.12.3.481
Studies on the cornea. II. The uptake and transport of colloidal particles by the living rabbit cornea in vitro.
G. Kaye (1962)
10.1002/JPS.2600621014
Altered bioavailability of drugs in the eye due to drug-protein interaction.
T. J. Mikkelson (1973)
Nanoparticles as drug carriers in ophthalmology.
T. Harmia (1987)
10.1002/jps.2600650909
Quantitative precorneal disposition of topically applied pilocarpine nitrate in rabbit eyes.
T. Patton (1976)
10.1016/0378-5173(89)90193-2
Evaluation of muco-adhesive properties and in vivo activity of ophthalmic vehicles based on hyaluronic acid
M. Saettone (1989)
10.1016/0039-6257(85)90109-2
Ocular drug bioavailability from topically applied liposomes.
V. H. Lee (1985)
10.1016/0378-5173(89)90167-1
The kinetics of in vitro release and the pharmacokinetics of miotic response in rabbits of gelatin and albumin microspheres with pilocarpine
Sorin E. Leucuţ¸a (1989)
10.1002/JPS.2600730509
Ocular delivery of pilocarpine from erodible matrices.
G. Grass (1984)
10.1002/JPS.2600680619
Vehicle effects on ocular drug bioavailability III: Shear-facilitated pilocarpine release from ointments.
J. Sieg (1979)
10.1002/JPS.2600631044
Letter: Albumin microspheres as vehicles for achieving specificity in drug delivery.
P. Kramer (1974)
In-vitro study of physostigmine salicylate and pilocarpine hydrochloride release from different gel formulations.
F. Habib (1986)
10.3109/02652049109021873
Studies on the transport pathway of PBCA nanoparticles in ocular tissues.
A. Zimmer (1991)
10.1016/0378-5173(86)90097-9
Activity of ophthalmic gels of betamethasone and phenylephrine hydrochloride in the rabbit's eye
M. Kassem (1986)
10.1016/0378-5173(83)90152-7
Liposomal ophthalmic drug delivery system I. Triamcinolone acetonide
K. Singh (1983)
10.1002/JPS.2600640811
Ocular evaluation of polyvinyl alcohol vehicle in rabbits.
T. Patton (1975)
10.1016/0378-5173(84)90056-5
Liposomal ophthalmic drug delivery system. II. Dihydrostreptomycin sulfate
K. Singh (1984)
10.1007/978-1-4613-1809-5_31
Polymeric Inserts for Sustained Ocular Delivery of Pilocarpine
M. Saettone (1986)
10.1016/0020-708X(70)90006-2
Preparation of metabolizable radioactive human serum albumin microspheres for studies of the circulation.
I. Zolle (1970)
10.1002/JPS.2600621207
Competitive inhibition of drug-protein interaction in eye fluids and tissues.
T. J. Mikkelson (1973)
10.1002/JPS.2600690735
Percorneal retention of topically instilled micronized particles.
J. Sieg (1980)



This paper is referenced by
Original Article: Pharmacological Nanomedicine Diclofenac-loaded biopolymeric nanosuspensions for ophthalmic application
Sagar M. Agnihotri (2009)
10.1208/s12249-009-9266-6
Development of an Ex Vivo Method for Evaluation of Precorneal Residence of Topical Ophthalmic Formulations
Q. Liu (2009)
10.1080/107175401317245886
Particle-Mediated Intravascular Delivery of Oligonucleotides to Tumors: Associated Biology and Lessons from Genotherapy
C. Dass (2001)
10.1081/DDC-120002997
Penetration Enhancers and Ocular Bioadhesives: Two New Avenues for Ophthalmic Drug Delivery
I. P. Kaur (2002)
10.1016/0169-409X(95)00017-2
Microspheres and nanoparticles used in ocular delivery systems
A. Zimmer (1995)
10.1080/026520499289202
Preparation of albumin microspheres by an improved process.
D. Katti (1999)
10.1201/9780824741990
The Blood-brain Barrier and Drug Delivery to the CNS
D. Begley (2000)
10.3109/02713680903261405
Cyclosporine A-Loaded Solid Lipid Nanoparticles: Ocular Tolerance and In Vivo Drug Release in Rabbit Eyes
E. Gökçe (2009)
10.1016/0168-3659(94)00059-4
Evaluation of pilocarpine-loaded albumin particles as controlled drug delivery systems for the eye. II. Co-administration with bioadhesive and viscous polymers
A. Zimmer (1995)
10.1016/j.nano.2008.07.003
Diclofenac-loaded biopolymeric nanosuspensions for ophthalmic application.
Sagar M. Agnihotri (2009)
10.1016/S0142-9612(02)00080-7
Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application.
R. Pignatello (2002)
Bioavibility Studies of Ocular Gels of Pilocarpine Microspheres
Sudha Rathod (2003)
10.1002/JPS.10227
Ocular tolerability of Eudragit RS100 and RL100 nanosuspensions as carriers for ophthalmic controlled drug delivery.
R. Pignatello (2002)
10.1016/B978-012513760-7/50063-0
Biopolymer and polymer nanoparticles and their biomedical applications
E. Nakache (2000)
10.1016/j.jconrel.2008.12.018
Polymeric nanoparticulate system: a potential approach for ocular drug delivery.
R. C. Nagarwal (2009)
10.22270/JDDT.V3I1.343
MICROSPHERES AS AN OCULAR DRUG DELIVERY SYSTEM- A REVIEW
Tejpal Yadav (2013)
10.1016/j.addr.2017.04.001
Nanoparticles for drug delivery to the anterior segment of the eye.
D. Janagam (2017)
10.1089/jop.2009.0005
Comparative study of topical application of timolol and verapamil in patients with glaucoma within 6 months.
Mohammad Reza Shayegan (2009)
Development of Acyclovir-loaded Bovine Serum Albumin Nanoparticles for Ocular Drug Delivery
Pawinee Noomwong (2012)
10.1080/03639040701384942
Chitosan Nanoparticles for Prolonged Delivery of Timolol Maleate
S. Agnihotri (2007)
10.1201/B15636-21
Prospective Corollary of Ophthalmic Nanomedicine: A Concept Shift toward Chitosan-Based Mucoadhesive Nanomedicine
Farhan J Ahmad (2013)
10.1201/9780824741990.CH11
Using Nanoparticles to Target Drugs to the Central Nervous System
R. Alyautdin (2000)
Ocular Delivery of Antisense Oligonucleotides Using Colloidal Carriers: Improving the Wound Repair After Corneal Surgery.
I. Rupenthal (2008)
10.1007/s40005-016-0250-3
Albumin-based potential drugs: focus on half-life extension and nanoparticle preparation
E. Lee (2016)
10.1016/j.jconrel.2011.07.031
Albumin-based nanoparticles as potential controlled release drug delivery systems.
Ahmed O Elzoghby (2012)
10.1517/17425247.2012.690733
Ocular drug delivery system: a reference to natural polymers
Priyanka Pahuja (2012)
10.1016/S0928-0987(02)00057-X
Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen.
R. Pignatello (2002)
10.1007/978-3-319-47691-9_9
Progress of Controlled Drug Delivery Systems in Topical Ophthalmology: Focus on Nano and Micro Drug Carriers
Ameeduzzafar Zafar (2016)
10.1080/10837450.2019.1616755
Thermosensitive hydrogel containing sertaconazole loaded nanostructured lipid carriers for potential treatment of fungal keratitis
N. Tavakoli (2019)
10.1002/9781118462157.CH17
Polymeric nanoparticles for food applications
C. Sabliov (2015)
10.1007/978-3-319-29346-2
Nano-Biomaterials For Ophthalmic Drug Delivery
Y. Pathak (2016)
10.1016/S1350-9462(97)00002-5
Ophthalmic drug delivery systems—Recent advances
C. L. Bourlais (1998)
See more
Semantic Scholar Logo Some data provided by SemanticScholar